Exon 3 β-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome

Background and aim: Activating β-catenin mutations in exon 3 have been implicated in colorectal tumorigenesis. Although reports to the contrary exist, it has been suggested that β-catenin mutations occur more often in microsatellite unstable (MSI+) colorectal carcinomas, including hereditary non-polyposis colorectal cancer (HNPCC), as a consequence of defective DNA mismatch repair. We have analysed 337 colorectal carcinomas and adenomas, from both sporadic cases and HNPCC families, to provide an accurate assessment of β-catenin mutation frequency in each tumour type. Methods: Direct sequencing of exon 3 of β-catenin. Results: Mutations were rare in sporadic (1/83, 1.2%) and HNPCC adenomas (1/37, 2.7%). Most of the sporadic adenomas analysed (80%) were small (<1 cm), and our data therefore differ from a previous report of a much higher mutation frequency in small adenomas. No oncogenic β-catenin mutations were identified in 34 MSI+ and 78 microsatellite stable (MSI−) sporadic colorectal cancers but a raised mutation frequency (8/44, 18.2%) was found in HNPCC cancers; this frequency was significantly higher than that in HNPCC adenomas (p = 0.035) and in both MSI− (p<0.0001) and MSI+ (p = 0.008) sporadic cancers. Mutations were more common in higher stage (Dukes’ stages C and D) cancers (p = 0.001). Conclusion: Exon 3 β-catenin mutations are associated specifically with malignant colorectal tumours in HNPCC; mutations appear not to result directly from deficient mismatch repair. Our data provide evidence that the genetic pathways of sporadic MSI+ and HNPCC cancers may be divergent, and indicate that mutations in the HNPCC pathway of colorectal tumorigenesis may be determined by selection, not simply by hypermutation.

[1]  M. Miyaki,et al.  Frequent activation of the β‐catenin‐Tcf signaling pathway in nonfamilial colorectal carcinomas with microsatellite instability , 2001, Genes, chromosomes & cancer.

[2]  K. Hoang-Xuan,et al.  Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites , 1998, Genes, chromosomes & cancer.

[3]  P. Soballe,et al.  Mutations in beta-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors. , 1997, Cancer research.

[4]  B. Leggett,et al.  DNA microsatellite instability and mismatch repair protein loss in adenomas presenting in hereditary non-polyposis colorectal cancer , 2000, Gut.

[5]  M. Pignatelli,et al.  β-catenin - A linchpin in colorectal carcinogenesis? , 2002 .

[6]  S. Y. Park,et al.  Development and applications of a beta-catenin oligonucleotide microarray: beta-catenin mutations are dominantly found in the proximal colon cancers with microsatellite instability. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  F. van Roy,et al.  Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas. , 1999, Cancer research.

[8]  W F Bodmer,et al.  Beta-catenin mutations in cell lines established from human colorectal cancers. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Y. Nakamura,et al.  Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. , 1998, Cancer research.

[10]  P. Polakis.  Wnt signaling and cancer. , 2000, Genes & development.

[11]  T. Iwama,et al.  Frequent Mutation of β-Catenin and APC Genes in Primary Colorectal Tumors from Patients with Hereditary Nonpolyposis Colorectal Cancer , 1999 .

[12]  G. Thomas,et al.  BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. , 1997, Cancer research.

[13]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[14]  Paul Polakis,et al.  Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly , 1996, Science.

[15]  Y. Yuasa,et al.  β-Catenin and adenomatous polyposis coli (APC) mutations in adenomas from hereditary non-polyposis colorectal cancer patients , 2000 .

[16]  L. Påhlman,et al.  Colorectal cancer with and without microsatellite instability involves different genes , 1999, Genes, chromosomes & cancer.

[17]  Jörg Stappert,et al.  β‐catenin is a target for the ubiquitin–proteasome pathway , 1997 .

[18]  C. Albrecht,et al.  Overexpression of Wnt target genes in adenomas of familial adenomatous polyposis patients. , 2002, Anticancer Research.

[19]  J. Wardle,et al.  Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial , 2002, The Lancet.

[20]  L. Aaltonen,et al.  Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC). , 2001, Cancer research.

[21]  A. Millar,et al.  Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. , 1999, Cancer research.

[22]  L. Aaltonen,et al.  Microsatellite instability in adenomas as a marker for hereditary nonpolyposis colorectal cancer. , 1999, The American journal of pathology.

[23]  Bert Vogelstein,et al.  Mutational Analysis of the APC/β-Catenin/Tcf Pathway in Colorectal Cancer , 1998 .

[24]  G. Chenevix-Trench,et al.  Genomic instability occurs in colorectal carcinomas but not in adenomas , 1993, Human mutation.

[25]  L. Roncucci,et al.  Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis. , 2001, Cancer research.

[26]  Akira Kikuchi,et al.  Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK‐3β and β‐catenin and promotes GSK‐3β‐dependent phosphorylation of β‐catenin , 1998 .